| Oncomethylome sluit licentie- en testovereenkomst met Merck |
| Belegger.nl - 10 Jun 11:00 |
| OncoMethylome sluit overeenkomst met Merck |
| Belegger.nl - 10 Jun 09:20 |
| Merck says wins appeal on first Vioxx case |
| Reuters - 29 May 17:00 |
| Merck settles state Vioxx probes, to pay $58 million |
| Reuters - 20 May 19:40 |
| Merck extends deadline for Vioxx settlement |
| Reuters - 2 May 06:00 |
| Merck hit hard by cholesterol drug rejection |
| Reuters - 29 Apr 18:01 |
| Merck voert winst op |
| Belegger.nl - 23 Apr 11:39 |
| Costs help Merck and Novartis, hit Lilly |
| Reuters - 21 Apr 20:00 |
| Winst Merck omhoog |
| Belegger.nl - 21 Apr 15:00 |
| Merck profit rises on gains from deal |
| Reuters - 21 Apr 14:00 |
| Researchers charge Merck misrepresented Vioxx data |
| Reuters - 15 Apr 22:41 |
| Schering, Merck hit by cholesterol drug fallout |
| Reuters - 31 Mar 14:20 |
| Group to test Merck AIDS drug in gel |
| Reuters - 11 Mar 17:00 |
| Merck obesity drug falls short in trial: analyst |
| Reuters - 10 Mar 17:00 |
| Bedrijfsresultaat farmaceut Merck omlaag |
| Belegger.nl - 18 Feb 09:40 |
| Merck reaches settlement in Medicaid rebate probe |
| Reuters - 7 Feb 19:40 |
| Merck posts loss on Vioxx charges |
| Reuters - 30 Jan 18:00 |
| Merck posts loss on Vioxx charges |
| Reuters - 30 Jan 17:00 |
| Merck posts loss on Vioxx charges, shares fall |
| Reuters - 30 Jan 16:40 |
| Merck posts loss on Vioxx charges |
| Reuters - 30 Jan 15:00 |
| Omstreden pijnstiller leidt tot verlies Merck |
| Belegger.nl - 30 Jan 14:40 |
| Merck profit plunges on Vioxx charges |
| Reuters - 30 Jan 14:00 |
| NY subpoenas Merck and Schering-Plough over Vytorin |
| Reuters - 27 Jan 06:00 |
| FDA says reviewing Merck, Schering-Plough drug |
| Reuters - 25 Jan 21:20 |
| Judge denies class in Fosamax cases against Merck |
| Reuters - 4 Jan 21:40 |
| Merck in $700 million schizophrenia deal |
| Reuters - 3 Jan 11:00 |
| Merck in $700 million schizophrenia deal |
| Reuters - 3 Jan 07:40 |
| Merck in $700 million schizophrenia deal |
| Reuters - 3 Jan 07:20 |
| Panel rejects Merck over-the-counter statin bid |
| Reuters - 14 Dec 06:00 |
| Reviewer questions Merck over-counter drug bid |
| Reuters - 11 Dec 19:00 |
| Reviewer questions Merck over-counter drug bid |
| Reuters - 11 Dec 18:40 |
| Merck issues cautious 2008 forecast |
| Reuters - 4 Dec 18:40 |
| Merck 2008 outlook range mostly below expectations |
| Reuters - 4 Dec 15:20 |
| Merck sees higher 2008 earnings as new drugs shine |
| Reuters - 4 Dec 14:40 |
| Merck sees higher 2008 earnings as new drugs shine |
| Reuters - 4 Dec 14:20 |
| Merck sees higher 2008 earnings as new drugs shine |
| Reuters - 4 Dec 13:40 |
| Addex signs deal with Merck & Co, shares rise |
| Reuters - 3 Dec 10:20 |
| Addex, Merck & Co sign $170.5 mln Parkinson's deal |
| Reuters - 3 Dec 08:40 |
| Merck agrees to pay $4.85 billion in Vioxx settlement |
| Reuters - 9 Nov 22:01 |
| Merck agrees to pay $4.85 bln in Vioxx settlement |
| Reuters - 9 Nov 21:00 |
| Merck agrees to pay $4.85 bln in Vioxx settlement |
| Reuters - 9 Nov 19:40 |
| Merck agrees to pay $4.85 bln in Vioxx settlement |
| Reuters - 9 Nov 19:20 |
| Merck agrees to pay $4.85 bln in Vioxx settlement |
| Reuters - 9 Nov 17:20 |
| Merck agrees to pay $4.85 bln in Vioxx settlement |
| Reuters - 9 Nov 15:40 |
| Merck agrees to pay $4.85 bln in Vioxx settlement |
| Reuters - 9 Nov 15:01 |
| Merck bevestigt schikking USD 4,85 mrd voor Vioxx-claims |
| Eurobench - 9 Nov 15:00 |
| Merck settles Vioxx claims for $4.85 billion |
| Reuters - 9 Nov 14:20 |
| Merck set for Vioxx settlement: report |
| Reuters - 9 Nov 13:20 |
| 'Merck schikt voor USD 4,85 mrd Vioxx-claims' |
| Eurobench - 9 Nov 13:20 |
| "Merck schikt klachten over Vioxx" |
| Belegger.nl - 9 Nov 13:20 |
| Merck seen set for $4.85 billion Vioxx settlement: |
| Reuters - 9 Nov 11:00 |
| Merck set for $4.85 billion Vioxx settlement: report |
| Reuters - 9 Nov 09:01 |
| Merck shares seen rising on growth: Barron's |
| Reuters - 28 Oct 17:20 |
| Merck maakt fors meer winst |
| Belegger.nl - 24 Oct 09:20 |
| Merck quarterly profit rises |
| Reuters - 22 Oct 17:41 |
| Merck maakt flink meer winst |
| Belegger.nl - 22 Oct 15:00 |
| Merck & Co. verhoogt opnieuw winstverwachting |
| Eurobench - 22 Oct 14:40 |
| Merck quarterly profit jumps |
| Reuters - 22 Oct 14:02 |
| Crucell handhaaft prognose ondanks afhaken Merck |
| Belegger.nl - 25 Sep 15:40 |
| Crucell herhaalt verwachtingen na wegvallen HIV-vaccin Merck |
| Eurobench - 25 Sep 15:00 |
| Crucell verliest tot 6,75% door wegvallen HIV-vaccin Merck |
| Eurobench - 24 Sep 13:00 |
| Crucell onderuit na mislukt HIV-onderzoek Merck |
| Belegger.nl - 24 Sep 10:40 |
| Merck jumps on Erbitux lung cancer survival news |
| Reuters - 11 Sep 13:40 |
| Crucell geeft Merck exclusief toegang tot vaccin-technologie |
| Eurobench - 10 Sep 09:20 |
| Crucell verstrekt licentie aan Merck & Co |
| Belegger.nl - 10 Sep 09:00 |
| Merck wins reversal of Vioxx class-action status |
| Reuters - 6 Sep 19:20 |
| Merck wins reversal of Vioxx class-action status |
| Reuters - 6 Sep 19:00 |
| Merck wins reversal of Vioxx class-action status |
| Reuters - 6 Sep 18:01 |
| Merck says NJ court overturns Vioxx class action |
| Reuters - 6 Sep 17:40 |
| Merck "good" cholesterol drug meets trial goals |
| Reuters - 2 Sep 16:40 |
| Merck "good" cholesterol drug meets trial goals |
| Reuters - 2 Sep 13:00 |
| Merck "good" cholesterol drug meets trial goals |
| Reuters - 2 Sep 09:00 |
| Merck boekt stevig meer winst |
| Belegger.nl - 25 Jul 09:40 |
| German Merck Q2 operating profit up 58 percent |
| Reuters - 25 Jul 08:20 |
| Merck shares jump on strong profit, raised forecast |
| Reuters - 23 Jul 20:40 |
| CORRECTED: Merck shares jump on strong profit, raised forecast |
| Reuters - 23 Jul 20:20 |
| Wall Street: Merck & Co uitschieter binnen Dow Jones |
| Eurobench - 23 Jul 20:00 |
| Merck shares jump on strong profit, raised forecast |
| Reuters - 23 Jul 19:40 |
| Merck profit jumps, raises forecast |
| Reuters - 23 Jul 14:40 |
| Futures rise on deals, profits; Merck gains |
| Reuters - 23 Jul 14:40 |
| Merck & Co. verhoogt opnieuw winstverwachting |
| Eurobench - 23 Jul 14:40 |
| Meer winst voor het Amerikaanse Merck |
| Belegger.nl - 23 Jul 14:40 |
| Merck profit jumps, raises forecast |
| Reuters - 23 Jul 14:00 |
| Federal judge throws out a Merck Vioxx victory |
| Reuters - 31 May 06:00 |
| Merck verkoopt Merck Generics aan Mylan voor EUR 4,9 mrd |
| Eurobench - 14 May 09:40 |
| Merck KGaA sells generics unit to Mylan for $6.6 bln |
| Reuters - 13 May 20:00 |
| Merck KGaA sells generics unit to Mylan for $6.6 bln |
| Reuters - 13 May 18:40 |
| Merck & Co. keen on small acquisitions: executive |
| Reuters - 13 May 18:00 |
| Merck sells generics unit |
| Reuters - 13 May 16:20 |
| Merck to sell generics unit to Mylan for $6.6 bln |
| Reuters - 13 May 12:00 |
| Merck to sell generics to Mylan for $6.6 bln |
| Reuters - 13 May 11:20 |
| Merck to sell generics to Mylan for $6.6 bln |
| Reuters - 13 May 11:00 |
| Brazil sidesteps patent on Merck AIDS drug |
| Reuters - 4 May 21:20 |
| Merck says FDA rejects Arcoxia drug |
| Reuters - 27 Apr 17:00 |
| Merck op nettoverlies door overnamekosten |
| Belegger.nl - 25 Apr 12:20 |
| Merck profit rises as new drugs fill void |
| Reuters - 19 Apr 15:00 |
| Merck boekt winststijging van 12% in 1ekw 2007 |
| Eurobench - 19 Apr 14:40 |
| Merck maakt meer winst |
| Belegger.nl - 19 Apr 14:40 |
| Merck profit rises as new drugs fill void |
| Reuters - 19 Apr 14:00 |
| Merck profit rises as new drugs fill void |
| Reuters - 19 Apr 13:40 |
Wie brengt u deze website? Dirk Dijksma's profile